Immune profiling leads to implications for immunotherapy for NF1-associated tumors
Neurofibromatosis type 1 (NF1)—an autosomal dominant disorder affecting approximately one in every 3,500 people—results in dysfunctional neurofibromin, a protein expressed throughout the body and involved in the RAS signaling ...
Jun 12, 2017